Literature DB >> 11506184

The uptake and metabolism of fructose-1,6-diphosphate in rat cardiomyocytes.

W D Ehringer1, B Chiang, S Chien.   

Abstract

Fructose-1,6-diphosphate (FDP) is a glycolytic intermediate which has been theorized to increase the metabolic activity of ischemic tissues. Here we examine the effects of externally applied FDP on cardiomyocyte uptake and metabolism. Adult rat cardiomyocytes were isolated and exposed to varying concentrations (0, 5, 25 and 50 mM) of FDP for either 1, 16 or 24 h of hypoxia (95% N2/5% CO2), each time period followed by a 1 h reoxygenation (95% air/5% CO2). The uptake of FDP by rat cardiomyocytes was more concentration-dependent than time-dependent. Furthermore, the uptake of FDP by the cardiomyocytes was similar in the hypoxia and normoxia treated cells. Alamar Blue, a redox indicator that is sensitive to metabolic activity, was used to monitor the effects of the FDP on cardiomyocyte metabolism. In the 1 h hypoxia or normoxia group, the 5, 10 and 25 mM FDP showed a significant increase in metabolism compared to the control cells. When the length of hypoxia was extended to 16 h, all doses of FDP were greater than control. And at the 24 h hypoxia or normoxia time period, only the 10, 25 and 50 mM FDP groups were greater than control. The results indicate a non-linear trend between the external concentration of FDP and the changes noted in metabolism. The findings from this study indicate that a narrow concentration range between 5-10 mM augments cardiomyocyte metabolism, but higher or lower doses may have little additional affect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506184     DOI: 10.1023/a:1010973806747

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Quantitative image analysis of F-actin in endothelial cells.

Authors:  W D Ehringer; S Yamany; K Steier; A Farag; F J Roisen; A Dozier; F N Miller
Journal:  Microcirculation       Date:  1999-12       Impact factor: 2.628

2.  A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I.

Authors:  K B Jonsson; A Frost; R Larsson; S Ljunghall; O Ljunggren
Journal:  Calcif Tissue Int       Date:  1997-01       Impact factor: 4.333

3.  Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures.

Authors:  M J White; M J DiCaprio; D A Greenberg
Journal:  J Neurosci Methods       Date:  1996-12-28       Impact factor: 2.390

4.  Acetylcholine-induced membrane potential changes in endothelial cells of rabbit aortic valve.

Authors:  M Ohashi; K Satoh; T Itoh
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death.

Authors:  S A Back; R Khan; X Gan; P A Rosenberg; J J Volpe
Journal:  J Neurosci Methods       Date:  1999-09-15       Impact factor: 2.390

6.  Role of gelsolin in the actin filament regulation of cardiac L-type calcium channels.

Authors:  A S Lader; D J Kwiatkowski; H F Cantiello
Journal:  Am J Physiol       Date:  1999-12

7.  Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart.

Authors:  J Weiss; B Hiltbrand
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle.

Authors:  C D Hardin; T M Roberts
Journal:  Am J Physiol       Date:  1994-12

9.  Lack of a direct metabolic effect of fructose, 1,6-diphosphate in ischemic myocardium.

Authors:  L J Eddy; D Chambers; S Honig; J M Downey
Journal:  Am J Physiol       Date:  1981-10

10.  Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism.

Authors:  I E Hassinen; E M Nuutinen; K Ito; S Nioka; G Lazzarino; B Giardina; B Chance
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  8 in total

1.  Direct energy delivery improves tissue perfusion after resuscitated shock.

Authors:  El Rasheid Zakaria; William D Ehringer; Nina Tsakadze; Na Li; R Neal Garrison
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Characterization of the high-affinity uptake of fructose-1,6-bisphosphate by cardiac myocytes.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

3.  Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.

Authors:  Michael Kuncewitch; Weng Lang Yang; Asha Jacob; Adam Khader; Matthew Giangola; Jeff Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2015-09-12       Impact factor: 3.982

4.  Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers.

Authors:  William D Ehringer; Susan Su; Benjamin Chiangb; William Stillwell; Sufan Chien
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

5.  Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats.

Authors:  Luciana M de Oliveira; Melissa G Simões Pires; Alessandra B Magrisso; Terezinha P Munhoz; Rafael Roesler; Jarbas R de Oliveira
Journal:  J Thromb Thrombolysis       Date:  2009-08-25       Impact factor: 2.300

6.  Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes.

Authors:  Thomas J Wheeler; John M McCurdy; Aaron denDekker; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

7.  Protection of rat cardiac myocytes by fructose-1,6-bisphosphate and 2,3-butanedione.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

8.  Fructose 1,6-Bisphosphate as a Protective Agent for Experimental Fat Grafting.

Authors:  Tao Lv; Yunpeng Gu; Jianhai Bi; Ning Kang; Zhigang Yang; Xin Fu; Qian Wang; Li Yan; Xia Liu; Yilin Cao; Ran Xiao
Journal:  Stem Cells Transl Med       Date:  2019-02-18       Impact factor: 6.940

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.